Daniel Tillett is a biotech entrepreneur and executive with over two decades of leadership experience, currently serving as CEO of Racura Oncology and founder/CEO of Nucleics, a company that builds software to improve DNA sequencing. He combines deep scientific credentials—a PhD in Biochemistry and Molecular Biology from UNSW—with hands-on product development and commercialization across oncology and genomic tools. As a non-executive director and active investor, he guides ASX-listed life-science companies and startups, bringing both boardroom strategy and technical insight. A former senior lecturer and angel investor, he has a track record of translating academic research into viable products and companies, often spotting opportunities at the intersection of software and molecular biology.
Contributions:7 commits, 1 PR, 3 pushes in 3 years 4 months
englishspellingreformbrowser
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.